<DOC>
	<DOCNO>NCT02106689</DOCNO>
	<brief_summary>The daily injection require superovulation , fertility treatment use injection stimulate woman 's ovary produce multiple egg , anxiety provoke process many woman deterrent treatment . Alternative needle-free injection system develop intention reduce needle phobia pain , provide similar result . However , needle-free system yet widely use woman infertility . The purpose study ass whether pain apprehension patient often associate needle injection , alleviate use new , Health Canada approve , needle-free system . The purpose current study ass whether patient satisfaction improve patient use needle free injection system daily self injection require superovulation induction compare patient use standard needle syringe .</brief_summary>
	<brief_title>Needle-Free Injections Gonadotropins Superovulation</brief_title>
	<detailed_description>Injectable medication call gonadotropin often necessary fertility treatment . Superovulation process use injection stimulate woman 's ovary produce multiple egg . Having multiple eggs mature increase woman 's chance least 1 egg fertilize . The daily injection require superovulation , anxiety provoke process many woman deterrent treatment . Alternative needle-free injection system develop intention reduce needle phobia pain , provide similar result . However , needle-free system yet widely use woman infertility . The purpose study ass whether pain apprehension patient often associate needle injection , alleviate use new , Health Canada approve , needle-free system . Studies show needle-free injection system effective standard self injection use delivery medication subcutaneously ( i.e. , deliver beneath skin ) - insulin , vaccination local anesthetic . To date , two study examine use needle-free injection specifically vitro fertilization . The result study show needle-free system successful standard injection promote ovarian stimulation achieve pregnancy . However , yet demonstrate whether patient think needle-free system easier use less painful administer standard injection . The purpose current study ass whether patient satisfaction improve patient use needle free injection system daily self injection require superovulation induction compare patient use standard needle syringe .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<criteria>Women undergo first cycle superovulation Age 1839 BMI 1835 kg/m2 Uterine cavity evaluation ( hysterosalpingogram , sonohysterogram , hysteroscopy ) normal precede 6 12 month Early follicular phase ( Day 2 Day 3 ) serum FSH &lt; 12 IU/L precede 12 month Subject able give inform consent At least 1 patent fallopian tube One semen analysis prior 12 month total motile count &gt; 10M Prior enrollment study Any prior early follicular phase serum FSH level â‰¥12 IU/L Previous ovarian stimulation gonadotropin Diabetes mellitus uncontrolled thyroid disease Abnormal uterine cavity , unresected submucosal fibroid , uterine septum , Mullerian anomaly bicornuate unicornuate uterus intrauterine adhesion Hydrosalpinx</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>infertility , superovulation , gonadotropin , needle free injection system</keyword>
</DOC>